Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Src/tubulin Inhibitor KX02

Known as: KX02, KX2-361 
A lipophilic, orally available inhibitor of both Src kinase activity and tubulin polymerization, with potential antineoplastic activity. Upon oral… 
National Institutes of Health

Related topics

Related topics

2 relations
Microtubule ProcessReceptor Tyrosine Kinase Inhibition

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma
PurposeA major challenge to developing new therapies for patients with malignant brain tumors is that relatively few small… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Abstract 5598: KX02, a novel therapeutic for glioma
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC Objectives: Over 20,000 new cases of primary… 
2006
2006
NORMAL CONDUCTING HIGH-GRADIENT STUDIES AT KEK
Normal-conducting high-frequency high-field studies have been pursued at XTF, which is a high power X-band RF facility of KEK… 
  • figure 3
  • figure 1
  • figure 2
  • figure 4
  • figure 7
2004
2004
PROGRESS TOWARD NLC/GLC PROTOTYPE ACCELERATOR STRUCTURES*
The accelerator structure groups for NLC (Next Linear Collider) and GLC (Global Linear Colliders) have successfully collaborated… 
  • table 1
  • figure 1
  • figure 2
  • figure 5
  • figure 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE